Blockade of α2-adrenoceptors by 1-(2-pyrimidinyl)-piperazine (PmP) in vivo and its relation to the activity of buspirone
- 1 March 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 147 (3), 343-350
- https://doi.org/10.1016/0014-2999(88)90167-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Specificity of Drugs as Tools in Psychopharmacology: Drugs That Interfere with Monoamine StoragePublished by Springer Nature ,2003
- Buspirone: review of its pharmacology and current perspectives on its mechanism of actionAmerican Journal Of Medicine, 1986
- 1-(2-Pyrimidinyl)-Piperazine as Active Metabolite of Buspirone in Man and RatPharmacology, 1986
- Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the ratXenobiotica, 1985
- Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivityNeuropharmacology, 1983
- Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidineLife Sciences, 1983
- Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the ratXenobiotica, 1983
- Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestineLife Sciences, 1982
- Noradrenergic agonists and antagonists: Effects on conditioned fear as measured by the potentiated startle paradigmPsychopharmacology, 1979
- On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the ratJournal of Pharmacy and Pharmacology, 1978